Mandarin In.sg Regulatory News (MDO)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, MALAYSIA, THE REPUBLIC OF SOUTH AFRICA, SWITZERLAND, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

To: Business Editor For immediate release

MANDARIN ORIENTAL INTERNATIONAL LIMITED

RESULTS OF 1 FOR 4 RIGHTS ISSUE

7th April 2015 - Mandarin Oriental International Limited (the 'Company') today announces that the 1 for 4 Rights Issue of 250,930,401 New Ordinary Shares at US$1.26 per New Ordinary Share announced on Thursday, 5th March 2015 closed for acceptances on Tuesday, 7th April 2015. The Company received valid acceptances in respect of 246,975,730 New Ordinary Shares, representing approximately 98.42 per cent. of the total number of New Ordinary Shares pursuant to the fully underwritten Rights Issue.

It is expected that the New Ordinary Shares in uncertificated form will be credited to CDP accounts before trading commences on Wednesday, 8th April 2015 and that definitive share certificates in respect of New Ordinary Shares in certificated form are expected to be despatched by post to registered shareholders by Monday, 20th April 2015, or if required such later date when the respective banker's draft is cleared.

It is expected that trading in the fully-paid New Ordinary Shares on the London Stock Exchange, the Bermuda Stock Exchange and the Singapore Exchange will commence on Wednesday, 8th April 2015. Prior to trading registered shareholders should, however, note the settlement requirements that may be applicable as definitive certificates for the New Ordinary Shares are not expected to be despatched by post before Monday, 20th April 2015.

The Company confirms that it has procured that Jardine Strategic Holdings Limited ('Jardine Strategic') will purchase all of the 3,954,671 New Ordinary Shares for which valid acceptances were not received at a price of US$1.60 per New Ordinary Share (compared with the closing price of US$1.60 on Tuesday, 7th April 2015).

The net proceeds from the placing of such New Ordinary Shares (after the deduction of the Issue Price of US$1.26 per New Ordinary Share and currency conversion costs, if any) will be paid (without interest) to those persons whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to their lapsed provisional allotments, save that individual amounts of less than US$5.00 will not be paid to such persons but will be aggregated and retained for the benefit of the Company.

The shareholding of Jardine Strategic (and, through Jardine Strategic, Jardine Matheson Holdings Limited) in the Company following the completion of the Rights Issue is 925,548,772 Ordinary Shares, being 73.77 per cent. of the Company's issued share capital.

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

Stuart Dickie (852) 2895 9288

J.P. Morgan Cazenove

Joint Corporate Broker

Ed Squire / Bronson Albery (44) 20 7742 4000

UBS

Joint Corporate Broker

Stuart Mackay (852) 2971 8888

David James (44) 20 7567 8421

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. ANY DECISION TO PURCHASE, OTHERWISE ACQUIRE, SUBSCRIBE FOR, SELL OR OTHERWISE DISPOSE OF ANY NEW ORDINARY SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS. COPIES OF THE PROSPECTUS WILL BE AVAILABLE ON PUBLICATION FROM THE OFFICE OF THE GROUP MANAGEMENT COMPANY, MANDARIN ORIENTAL HOTEL GROUP INTERNATIONAL LIMITED, AT 7TH FLOOR, 281 GLOUCESTER ROAD, CAUSEWAY BAY, HONG KONG AND ON THE COMPANY'S WEBSITE: WWW.MANDARINORIENTAL.COM/INVESTORS/REGULATORY-ANNOUNCEMENTS/.

J.P. Morgan Cazenove is authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. J.P. Morgan Cazenove is acting as corporate broker for the Company and is acting for no one else in connection with the Rights Issue and will not regard any other person as a client in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, or for providing advice in connection with the Rights Issue or any other matter, transaction or arrangement referred to in this announcement.

UBS is authorized and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. UBS is acting as corporate broker for the Company and is acting for no one else in connection with the Rights Issue and will not regard any other person as a client in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, or for providing advice in connection with the Rights Issue or any other matter, transaction or arrangement referred to in this announcement.

The Rights Issue is being underwritten by Jardine Strategic.

This announcement has been issued by, and is the sole responsibility of, the Company. Apart from the responsibilities and liabilities, if any, which may be imposed on Jardine Strategic, J.P. Morgan Cazenove and UBS under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder or any other applicable regulatory regime, none of Jardine Strategic, J.P. Morgan Cazenove or UBS accepts any responsibility or liability whatsoever and makes no representation or warranty, express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by them, or on their behalf, in connection with the Company, the Nil Paid Rights, the Nil Paid Rights Allocations, the New Ordinary Shares or the Rights Issue. Jardine Strategic, J.P. Morgan Cazenove and UBS accordingly disclaim, to the maximum extent permitted by law, all and any responsibility and liability, whether arising in tort, contract or otherwise, which they might otherwise be found to have in respect of this announcement or any such statement.

The information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from Canada, Japan, Malaysia, the Republic of South Africa, Switzerland, the United States (the 'Restricted Territories') or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The securities to be issued in connection with the Rights Issue (the 'Securities') have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws.

This announcement is for information purposes only and does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in any jurisdiction and should not be relied upon in connection with any decision to subscribe for or acquire any of the Securities. In particular, this announcement does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the Restricted Territories or any other jurisdiction in which such an offer or solicitation would be unlawful.

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement.

This announcement and the information contained herein does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The Securities have not been and will not be registered under the US Securities Act of 1933 (the 'Securities Act'), and may not be offered or sold in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States or the other Restricted Territories. Accordingly, unless an exemption under the relevant securities law is applicable, the Securities may not be offered, sold, taken up, exercised, renounced, resold, delivered or distributed, directly or indirectly, in or into the United States or the other Restricted Territories or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. There will be no public offering of the Securities in the United States.

- end -